Skip to main content
. 2022 Nov 24;12(3):2875–2884. doi: 10.1002/cam4.5202

TABLE 1.

Characteristics individuals with variant of uncertain significance (VUS) across three to four study sites (N = 2715)

Variable Category Cooper MD Anderson OhioHealth Baptist Total
n = 515 (%) n = 1685 (%) n = 358 (%) n = 157 (%) N = 2715 (%)
Date of genetic counseling 2013–2018 2013–2019 2014–2018 2014–2018 2013–2019
Sex Female 497 (96.50) 1392 (82.61) 337 (94.13) 147 (93.63) 2373 (87.40)
Male 36 (6.99) 293 (17.39) 21 (5.87) 10 (6.37) 360 (13.26)
Race/Ethnicity NH Asian 17 (3.30) 138 (8.19) 13 (3.63) 3 (1.91) 171 (6.30)
Hispanic or Latino 44 (8.54) 252 (14.96) 4 (1.12) 0 (0.00) 300 (11.05)
NH Black 90 (17.48) 206 (12.23) 42 (11.73) 31 (19.75) 369 (13.59)
NH White 349 (67.77) 1039 (61.66) 291 (81.28) 118 (75.16) 1797 (66.19)
Other 11 (2.14) 17 (1.01) 2 (0.56) 5 (3.18) 35 (1.29)
Unknown 4 (0.78) 33 (1.96) 6 (1.68) 0 (0.00) 43 (1.58)
Personal history of cancer Breast 270 (52.43) 820 (48.66) 260 (72.63) 80 (50.96) 1350 (49.72)
Ovarian 15 (2.91) 123 (7.30) 24 (6.70) 19 (12.1) 162 (5.97)
Colorectal 9 (1.75) 138 (8.19) 21 (5.87) 6 (3.82) 168 (6.19)
Other 94 (18.25) 525 (31.16) 31 (8.66) 8 (5.1) 650 (23.94)
Unaffected 127 (24.66) 79 (4.69) 22 (6.15) 44 (28.03) 228 (8.40)
Genetic testing year 2002–2009 2 (0.39) 12 (0.71) 0 (0.00) 0 (0.00) 14 (0.52)
2010–2012 0 (0.00) 12 (0.71) 0 (0.00) 1 (0.64) 13 (0.48)
2013–2015 93 (18.06) 273 (16.20) 44 (12.29) 4 (2.55) 414 (15.25)
2016–2018 401 (77.86) 919 (54.54) 304 (84.92) 151 (96.18) 1775 (65.38)
2019–2020 18 (3.50) 464 (27.54) 10 (2.79) 1 (0.64) 493 (18.16)
Test result type VUS only 458 (88.93) 1493 (88.61) 320 (89.39) 144 (91.72) 2415 (88.95)
VUS + P/LP 57 (11.07) 192 (11.39) 38 (10.61) 13 (8.28) 300 (11.05)
Variant reclassification 104 (20.19) 81 (4.81) 27 (7.54) 14 (8.92) 226 (8.32)